e-learning
resources
Berlin 2001
Tuesday 25.09.2001
Sourcing material for TB diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neopterin as an indicator of the activity of tuberculosis
P. M. Minchev, A. I. Maleeva, M. P. Zheleva (Sofia, Bulgaria)
Source:
Annual Congress 2001 - Sourcing material for TB diagnosis
Session:
Sourcing material for TB diagnosis
Session type:
Poster Discussion
Number:
3319
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. M. Minchev, A. I. Maleeva, M. P. Zheleva (Sofia, Bulgaria). Neopterin as an indicator of the activity of tuberculosis. Eur Respir J 2001; 16: Suppl. 31, 3319
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Neopterin levels differential diagnosis of active and inactive pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006
Urinary neopterin levels discriminate active from latent mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection
Source: Eur Respir J 2013; 42: 547-550
Year: 2013
Elevated serum adiponectin level in patients with
mycobacterium avium-intracellulare
complex pulmonary disease
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008
The diagnosis value of the ADA isoenzymes activity in tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 155s
Year: 2003
Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1237-1238
Year: 2011
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary
Mycobacterium avium-intracellulare
complex (MAC) disease
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Usefulness of serum procalcitonin levels in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 371
Year: 2011
Monocyte/neutrophil phagocytic activity ratio in differentiating tuberculosis from sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011
Serum concentration of cytokines before and during treatment in patients with active tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002
High serum CA-125 level in active pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 415s
Year: 2005
Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Relation of D-dimer levels and extent of disease in patients with active tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
Serum IFN-γ and TNF-α levels in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Is neopterin concentration predictive in latent tuberculosis infection in health workers?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept